Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Merk

Showing results (21-30 of 165) with videos related to

Pageof 17
Sort By:
Journal of Medicinal Chemistry|July 24, 2018
Polypharmacology by Design: A Medicinal Chemist's Perspective on Multitargeting CompoundsEwgenij Proschak, Holger Stark, Daniel Merk
Molecules (Basel, Switzerland)|April 23, 2022
A Consensus Compound/Bioactivity Dataset for Data-Driven Drug Design and ChemogenomicsLaura Isigkeit, Apirat Chaikuad, Daniel Merk
Journal of Medicinal Chemistry|July 12, 2021
Targeting Nuclear Receptors in Neurodegeneration and NeuroinflammationSabine Willems, Daniel Zaienne, Daniel Merk
Kidney360|April 4, 2022
Multi-Target Drugs for Kidney DiseasesJohn D Imig, Daniel Merk, Eugen Proschak
Current Topics in Medicinal Chemistry|November 13, 2014
Medicinal chemistry and pharmacological effects of Farnesoid X Receptor (FXR) antagonistsChristina Lamers, Manfred Schubert-Zsilavecz, Daniel Merk
Expert Opinion on Drug Discovery|November 23, 2013
Characterizing ligands for farnesoid X receptor--available in vitro test systems for farnesoid X receptor modulator developmentDaniel Merk, Dieter Steinhilber, Manfred Schubert-Zsilavecz
Expert Opinion on Therapeutic Patents|June 16, 2012
Therapeutic modulators of peroxisome proliferator-activated receptors (PPAR): a patent review (2008-present)Christina Lamers, Manfred Schubert-Zsilavecz, Daniel Merk
Chemmedchem|June 19, 2024
Azologs of the Fatty Acid Mimetic Drug Cinalukast Enable Light-Induced PPARα ActivationMinh Sai, Niels van Herwijnen, Daniel Merk
Future Medicinal Chemistry|June 2, 2012
Medicinal chemistry of farnesoid X receptor ligands: from agonists and antagonists to modulatorsDaniel Merk, Dieter Steinhilber, Manfred Schubert-Zsilavecz
Journal of Medicinal Chemistry|March 3, 2017
Opportunities and Challenges for Fatty Acid Mimetics in Drug DiscoveryEwgenij Proschak, Pascal Heitel, Lena Kalinowsky, et al.
Pageof 17

Showing results (21-30 of 165) with videos related to

Sort By:
Pageof 17
Journal of Medicinal Chemistry|July 24, 2018
Polypharmacology by Design: A Medicinal Chemist's Perspective on Multitargeting CompoundsEwgenij Proschak, Holger Stark, Daniel Merk
Molecules (Basel, Switzerland)|April 23, 2022
A Consensus Compound/Bioactivity Dataset for Data-Driven Drug Design and ChemogenomicsLaura Isigkeit, Apirat Chaikuad, Daniel Merk
Journal of Medicinal Chemistry|July 12, 2021
Targeting Nuclear Receptors in Neurodegeneration and NeuroinflammationSabine Willems, Daniel Zaienne, Daniel Merk
Kidney360|April 4, 2022
Multi-Target Drugs for Kidney DiseasesJohn D Imig, Daniel Merk, Eugen Proschak
Current Topics in Medicinal Chemistry|November 13, 2014
Medicinal chemistry and pharmacological effects of Farnesoid X Receptor (FXR) antagonistsChristina Lamers, Manfred Schubert-Zsilavecz, Daniel Merk
Expert Opinion on Drug Discovery|November 23, 2013
Characterizing ligands for farnesoid X receptor--available in vitro test systems for farnesoid X receptor modulator developmentDaniel Merk, Dieter Steinhilber, Manfred Schubert-Zsilavecz
Expert Opinion on Therapeutic Patents|June 16, 2012
Therapeutic modulators of peroxisome proliferator-activated receptors (PPAR): a patent review (2008-present)Christina Lamers, Manfred Schubert-Zsilavecz, Daniel Merk
Chemmedchem|June 19, 2024
Azologs of the Fatty Acid Mimetic Drug Cinalukast Enable Light-Induced PPARα ActivationMinh Sai, Niels van Herwijnen, Daniel Merk
Future Medicinal Chemistry|June 2, 2012
Medicinal chemistry of farnesoid X receptor ligands: from agonists and antagonists to modulatorsDaniel Merk, Dieter Steinhilber, Manfred Schubert-Zsilavecz
Journal of Medicinal Chemistry|March 3, 2017
Opportunities and Challenges for Fatty Acid Mimetics in Drug DiscoveryEwgenij Proschak, Pascal Heitel, Lena Kalinowsky, et al.
Pageof 17